MoneyWorks4Me

Indoco Remedies - Quaterly Results

16 May 2024 Evaluate
The Total revenue for the quarter ended March 2024 of  Rs. 4454.90 millions remain, more or less, the same.A good growth in profit of 48.05% reported to Rs. 375.60  millions over Rs. 253.70 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 614.10 millions from 646.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 4454.90 4274.60 4.22 17908.10 16666.90 7.45 17908.10 16666.90 7.45
Other Income 40.50 4.90 726.53 85.10 23.30 265.24 85.10 23.30 265.24
PBIDT 614.10 646.60 -5.03 2664.90 2872.20 -7.22 2664.90 2872.20 -7.22
Interest 109.10 86.40 26.27 368.20 250.30 47.10 368.20 250.30 47.10
PBDT 702.30 560.20 25.37 2412.00 2621.90 -8.01 2412.00 2621.90 -8.01
Depreciation 237.30 176.90 34.14 879.80 706.00 24.62 879.80 706.00 24.62
PBT 465.00 383.30 21.31 1532.20 1915.90 -20.03 1532.20 1915.90 -20.03
TAX 89.40 129.60 -31.02 365.80 502.30 -27.17 365.80 502.30 -27.17
Deferred Tax -15.20 6.10 -349.18 38.10 -49.70 -176.66 38.10 -49.70 -176.66
PAT 375.60 253.70 48.05 1166.40 1413.60 -17.49 1166.40 1413.60 -17.49
Equity 184.40 184.30 0.05 184.40 184.30 0.05 184.40 184.30 0.05
PBIDTM(%) 13.78 15.13 -8.87 14.88 17.23 -13.65 14.88 17.23 -13.65
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..